AI Article Synopsis

  • Interstitial lung disease (ILD) is a common complication in primary Sjögren's disease (pSD), but its long-term impact on lung function and patient outcomes is not well understood.
  • A study of 73 pSD-ILD patients over an average of 9.3 years found that while lung function was generally stable, a significant portion experienced declines, particularly those with specific health characteristics.
  • Key findings include two groups with different lung function trajectories: one with stable lung function and one with a decline of approximately 2.4% per year, where the latter group faced higher risks of death or needing a lung transplant.

Article Abstract

Background: Interstitial lung disease (ILD) is common in primary Sjögren's disease (pSD); its functional course is poorly known. Our aim was to characterise the long-term functional course and prognosis in patients with pSD-ILD. We determined the role of baseline demographic and clinical variables in the evolution of lung function and identified risk factors for death or transplantation.

Methods: In a retrospective observational cohort study, patients with pSD and ILD were retrospectively identified from two French ILD centres. Forced vital capacity (FVC) and diffusing capacity of the lungs for carbon monoxide ( ) slopes were obtained from joint models. Latent class mixed models identified clusters of FVC and trajectories.

Results: We included 73 patients (63% women, mean age 63 years), with a median follow-up of 9.3 years. At baseline, mean FVC was 73±21% and 51±16%. On average, FVC was stable, while there was an annual decline in of 1% of the predicted value. Male sex, a pattern of usual interstitial pneumonia (UIP) or indeterminate for UIP on high-resolution computed tomography (HRCT), and features of fibrosis on HRCT, were associated with an accelerated decline in FVC and .

Conclusion: We identified clusters of lung function evolution. 1) Two FVC trajectories: patients with stable FVC (n=56, 78%); patients with FVC decline (n=16, 22%) of 2.4% per year, characterised by a low baseline (39%) and a higher risk of death or transplantation (HR 52, 95% CI 10-273). 2) Three trajectories: patients with stable (n=44, 66%); patients with a slow decline in (n=12, 18%) of 2.8% per year; patients with a rapid decline in (n=11, 16%) of 4.8% per year, characterised by a low baseline (41%) and a higher risk of death or transplantation (HR 156, 95% CI 18-1352).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11513999PMC
http://dx.doi.org/10.1183/23120541.00384-2024DOI Listing

Publication Analysis

Top Keywords

functional course
12
long-term functional
8
interstitial lung
8
lung disease
8
patients
8
lung function
8
fvc
8
identified clusters
8
trajectories patients
8
patients stable
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!